DIN 02389975 — TRETTEN 2500 UNIT
TRETTEN is a powder for solution of Catridecacog marketed by NOVO NORDISK CANADA INC. The full Catridecacog monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02389975
- Brand name
- TRETTEN
- Active ingredient
- Catridecacog
- Strength
- 2500 UNIT
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- NOVO NORDISK CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Recombinant coagulation Factor XIII A-subunit (antihemorrhagic)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.